A review on approaches to bio distribution studies about gold and silver engineered nanoparticles by inductively coupled plasma mass spectrometry

Microchemical Journal

Volumn 105, Issue , 2012, Pages 39-43

  Krystek, Petra ^a  

^a INSTITUTE FOR ENVIRONMENTAL STUDIES   (Netherlands)

Author keywords

Bio distribution studies; Engineered nanoparticles; Gold; ICP MS; Silver

Indexed keywords

EID: 84867850384     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.microc.2012.02.008     Document Type: Article

References (55)

1. ISO/TS-27687 ISO Technical Specification. First Edition 2008-08-15, Corrected Version 2009-02-01 2009.
2. Krystek P., Ulrich A., Garcia C.C., Manohar S., Ritsema R. Application of plasma spectrometry for the analysis of engineered nanoparticles in suspensions and products. J. Anal. At. Spectrom. 2011, 26:1701-1721.
3. Schmidt K., Riediker M. Use of nanoparticles in Swiss industry: a targeted survey. Environ. Sci. Technol. 2008, 42:2253-2260.
4. Som C., Berges M., Chaudhry Q., Dusinska M., Fernandes T.F., Olsen S.I., Nowack B. The importance of life cycle concepts for the development of safe nanoproducts. Toxicology 2010, 269:160-169.
5. Kaounides L., Yu H., Harper T. Nanotechnology innovationand applications in textiles industry: current markets and future growth trends. Mater. Technol. 2007, 22:209-237.
6. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
7. Gazsó A., Greßler S., Schiemer F., Luther W. Nano. Chancen und Risiken aktueller Technologien, in Nano 2007, 39-59. Springer, Vienna.
8. Benn T.M., Westerhoff P. Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 2008, 42:4133-4139.
9. Kaegi R., Sinnet B., Zuleeg S., Hagendorfer H., Mueller E., Vonbank R., Boller M., Burkhardt M. Release of silver nanoparticles from outdoor facades. Environ. Pollut. 2010, 158:2900-2905.
10. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 2008, 176:1-12.
11. Leinenbach C.G., Bissig V., Gattiker F., Klotz U.E. Shielding gas brazing of martensitic stainless steel with copper free silver based filler metals. Sci. Technol. Weld. Joining 2007, 12:708-717.
12. Limbach L.K., Wick P., Manser P., Grass R.N., Bruinink A., Stark W.J. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 2007, 41:4158-4163.
13. Marquis B.J., Love S.A., Braun K.L., Haynes C.L. Analytical methods to assess nanoparticle toxicity. Analyst 2009, 134:425-439.
14. 2, ZnO, Ag, CNT, fullerenes) for different regions. Environ. Sci. Technol. 2009, 43:9216-9222.
15. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdorster E. Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part. Fibre Toxicol. 2006, 3:11-46.
16. WEF http://www3.weforum.org/docs/WEF_GlobalRisks_Report_2010.pdf.
17. Oberdoerster G., Oberdoerster E., Oberdoerster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Heal. Perspect. 2005, 113:823-839.
18. Oberdoerster G., Stone V., Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 2007, 1:2-25.
19. Marambio-Jones C., Hoek E.M.V. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J. Nanopart. Res. 2010, 12:1531-1551.
20. Krug H.F., Wick P. Nanotoxikologie - eineinterdisziplinäre Herausforderung. Angew. Chem. 2011, 123:1294-1314.
21. Khlebtsov N., Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 2011, 40:1647-1671.
22. D. Lankveld, personal, communication, 2009.
23. P. Krystek, personal, communication, 2011.
24. de Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J.A.M., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
25. Lankveld D., Rayavarapu R., Krystek P., Oomen A., Verharen H., van Leeuwen T., Manohar S. Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats. Nanomedicine 2010, 6:339-349.
26. Lankveld D., Oomen A., Krystek P., Neigh A., Troost - de Jong A., Noorlander C., Hagens W., de Jong W. Effect of size on tissue distribution and accumulation of silver nanoparticles. Biomaterials 2010, 31:8350-8361.
27. Huda S., Smoukov S.K., Nakanishi H., Kowalczyk B., Sishop K., Grzybowski B.A. ACS Appl. Mater. Interfaces 2010, 2:1206-1210.
28. Krystek P., Ritsema R. Determination of uranium in urine - measurement of isotope ratios and quantification by use of inductively coupled plasma mass spectrometry. Anal. Bioanal. Chem. 2002, 374:226-229.
29. Krystek P., Ritsema R. An incident study about acute and chronic human exposure to uranium by high-resolution inductively coupled plasma mass spectrometry (HR-ICPMS). Int. J. Hyg. Environ. Health 2009, 212:76-81.
30. De Boer J.L.M., Ritsema R., Piso S., Van Staden H., Van Den Beld W. Practical and quality-control aspects of multi-element analysis with quadrupole ICP-MS with special attention to urine and whole blood. Anal. Bioanal. Chem. 2004, 379:872-880.
31. Montaser A. Inductively coupled plasma mass spectrometry 1998, Wiley VCH, New York.
32. Jakubowski N., Moens L., Vanhaecke F. Spectrochim. Acta, Part B 1998, 53:1739-1763.
33. Audi G., Wapstra A.H. Nucl. Phys. 1995, A595:409-480.
34. Krystek P., Ritsema R. The determination of selected elements in groundwater by high resolution inductively coupled plasma mass spectrometry - a validation assessment. Int. J. Environ. Anal. Chem. 2009, 89:331-345.
35. Sadauskas E., Danscher G., Stoltenberg M., Vogel U., Larsen A., Wallin H. Gold nanoparticles: pharmacological nanomedicine, protracted elimination of gold nanoparticles from mouse liver. Nanomed. Nanotechnol. Biol. Med. 2009, 5:162-169.
36. Takenaka S., Karg E., Kreyling W.G., Lentner B., Moeller W., Behnke-Semmler M., Jennen L., Walch A., Michalke B., Schramel P., Heyder J., Schulz H. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal. Toxicol. 2006, 18:733-740.
37. J. Langrish, P. Krystek, F.R. Cassee, personal, communication, 2011.
38. Hirn S., Semmler-Behnke M., Schleh C., Wenk A., Lipka J., Schaffler M., Takenaka S., Moller W., Schmod G., Simon U., Kreyling W.G. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration 2011, 77:407-416.
39. 2 particles. J. Phys. Chem. B 2001, 105:3441-3452.
40. Khlebtsov N.G., Dykman L.A. Optical properties and biomedical applications of plasmonic nanoparticles. J. Quant. Spectrosc. Radiat. Transfer 2010, 111:1-35.
41. Kennedy L.C., Bickford L.R., Lewinski N.A., Coughlin A.J., Hu Y., Day E.S., West J.L., Drezek R.A. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 2011, 7:169-183.
42. Casals E., Vazquez-Campos S., Bastus N.G., Puntes V. Distribution, potential toxicity of engineered inorganic nanoparticles and carbon nanostructures in biological systems. TRAC, Trends Anal. Chem. 2008, 27:672-683.
43. Niidome T., Yamagota M., Okamoto Y., Akiyama Y., Takahashi H., Kawano T., Katayama Y., Niidome Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Controlled Release 2006, 114:343-347.
44. Huang X.H., Peng X.H., Wang Y.Q., Wang Y.X., Shin D.M., El-Sayed M.A., Nie S.M. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010, 4. 5887-596.
45. Lipka J., Semmler-Behnke M., Sperling R.A., Wenk A., Takenaka S., Schleh C., Kissel T., Parak W.J., Kreyling W.G. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 2010, 31:6574-6581.
46. Zhang G.D., Yang Z., Lu W., Zhang R., Huang Q., Tian M., Li L., Liang D., Li C. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30:1928-1936.
47. Rayavarapu R., Ungureann C., Krystek P., van Leeuwen T., Manohar S. Gold nanorods, hexadecyltrimethylammonium bromide (CTAB) products and iodide impurities. Langmuir 2010, 26:5050-5055.
48. Li X., Zhou H.Y., Yang L., Du G.Q., Pai-Pandiker A.S., Huang X.F., Yang B. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles. Biomaterials 2011, 32:2540-2545.
49. Wang C.H., Liu C.J., Wang C.L., Hua T.E., Oblioscam J.M., Le K.H., Hwu Y., Yang C.S., Liu R.S., Li H.M., Je J.H., Margaritondo G. Optimizing the size and surface properties of polyethylene glycol (PEG)-gold nanoparticles by intense x-ray irradiation. J. Phys. D Appl. Phys. 2008, 41. Art. Nr. 195301.
50. Arinida A., Janat-Amsbury M.M., Ray A., Peterson C.M., Ghehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution, uptake by macrophages. Eur. J. Pharm. Biopharm. 2011, 77:417-423.
51. Wang C.H., Liu C.J., Chien C.C., Chen H.T., Hua T.E., Leng W.H., Chen H.H., Kempsom I.M., Hwu Y., Hsiao M., Lai T.C., Wang J.L., Yang C.S., Lin H.M., Chen Y.J., Margaritondo G. X-ray synthesized PEGylated (polyethylene glycol coated) gold nanoparticles in mice strongly accumulate in tumors. Mater. Chem. Phys. 2011, 126. 352-256.
52. Tang J.L., Xiong L., Zhou G.F., Wang S., Wang J.Y., Liu L., Li J.G., Yuan F.Q., Lu S.F., Wan Z.Y., Chou L.S., Xi T.F. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J. Nanosci. Nanotechnol. 2010, 10:6313-6317.
53. Garza-Ocanas L., Ferrer D.A., Burt J., Diaz-Torres L.A., Cabrera M.R., Rodriguez V.T., Rangel R.L., Rommaovicz D., Jose-Yacaman M. Biodistribution and long-term fate of silver nanoparticles. Metallomics 2010, 2:204-210.
54. Blank F., Gehr P., Rothen-Rutishauser B. In vitro human lung cell culture models to study the toxic potential of nanoparticles 2009, John Wiley & Sons, Ltd.
55. Rothen-Rutishauser B.M., Kiama S.C., Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am. J. Respir. Cell Mol. Biol. 2005, 32:281-289.